Tag: Hatch-Waxman Act

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Sheezus Talks - 14 Mar, 2026

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents

Paragraph IV patent challenges let generic drug makers legally fight brand patents under the Hatch-Waxman Act. This system has saved U.S. consumers over $1.2 trillion since 1990 by speeding up access to cheaper medicines.

Authorized Generics: How Brand Drug Companies Stay Competitive After Patent Expiry
Sheezus Talks - 23 Jan, 2026

Authorized Generics: How Brand Drug Companies Stay Competitive After Patent Expiry

Authorized generics let brand drugmakers stay competitive after patents expire by selling identical drugs under private labels. They lower prices, confuse patients, and reshape generic markets.